immuno-oncology

News

Bristol-Myers Squibb is to work with drug delivery specialist Halozyme to create an injectable form of its blockbuster immunotherapy Opdivo.

News

AstraZeneca (AZ) has tried to put a brave face on today’s news that its immunotherapy combination is unlikely to be a contender in lung cancer.

News

Immunocore, one of UK biotech's brightest hopes, has selected a third target as part of its immuno-oncology partnership with GlaxoSmithKline.

Views & Analysis

Assessing the global challenges inhibiting immuno-oncology market access.

News

For the first time, FDA approves drug on the basis of biomarkers, rather than location.

Views & Analysis

The cancer challenge is affecting more and more people worldwide, with 21 million cases expected by 2030.